Private health service provider Bupa is set to improve the quality of its cancer insurance.
Bupa will no longer sell corporate health insurance schemes featuring overall cost or time limits on cancer treatment.
The company highlighted the fact that cancer treatment costs increased sharply in 2005 and 2006 due to the introduction of new drugs.
In response to this the health insurance market developed strategies to limit financial exposure for client businesses.
However, research has found that these limits can leave patients who claim on their policies vulnerable at critical points in their treatment.
Dr Natalie-Jane Macdonald, managing director at Bupa Health and Wellbeing, explained that the company has developed "better, fairer ways of controlling healthcare costs" that will not compromise the outcomes of a patient's treatment.
She added: "We work closely with our clients to help them to provide their employees with the best quality healthcare at a sustainable affordable cost, and this remains a priority for us.
"We have developed better, fairer ways of controlling healthcare costs without compromising the experience and outcomes of patients at a difficult time in their lives."